What Stoke Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 12 | 83 |
| Total trades | 15 | 104 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 42,250 | 261,194 |
| Disposed | 34,594 | 280,553 |
| Net activity | +7,656 | −19,359 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Allan Jonathan | GENERAL COUNSEL & CORP SEC | Oct 02 | Open-market sale · S | −627 | $26.33 | −$16.5K | 20,598 |
| Ticho Barry | CHIEF MEDICAL OFFICER | Oct 01 | Open-market sale · S | −1,051 | $26.16 | −$27.5K | 19,059 |
| Ticho Barry | CHIEF MEDICAL OFFICER | Sep 01 | Open-market sale · S | −1,600 | $31.06 | −$49.7K | 20,110 |
| Ticho Barry | CHIEF MEDICAL OFFICER | Sep 01 | Open-market sale · S | −3,945 | $30.51 | −$120K | 21,710 |
| Ticho Barry | CHIEF MEDICAL OFFICER | Aug 18 | Open-market sale · S | −242 | $32.47 | −$7.86K | 25,655 |
| Ticho Barry | CHIEF MEDICAL OFFICER | Aug 18 | Open-market sale · S | −4,525 | $32.01 | −$145K | 25,897 |
| Kaye Edward M. Md | Director | Aug 18 | Open-market sale · S | −637 | $32.47 | −$20.7K | 124,557 |
| Kaye Edward M. Md | Director | Aug 18 | Open-market sale · S | −11,930 | $32.01 | −$382K | 125,194 |
| Allan Jonathan | GENERAL COUNSEL & CORP SEC | Aug 18 | Open-market sale · S | −145 | $32.47 | −$4.71K | 21,225 |
| Allan Jonathan | GENERAL COUNSEL & CORP SEC | Aug 18 | Open-market sale · S | −2,716 | $32.01 | −$86.9K | 21,370 |
| Ticho Barry | CHIEF MEDICAL OFFICER | Aug 14 | Exercise / conversion · M | +10,000 | — | — | 30,422 |
| Kaye Edward M. Md | Director | Aug 14 | Exercise / conversion · M | +26,250 | — | — | 137,124 |
| Allan Jonathan | GENERAL COUNSEL & CORP SEC | Aug 14 | Exercise / conversion · M | +6,000 | — | — | 24,086 |
| Ticho Barry | CHIEF MEDICAL OFFICER | Aug 03 | Open-market sale · S | −1,269 | $29.45 | −$37.4K | 20,422 |
| Ticho Barry | CHIEF MEDICAL OFFICER | Aug 03 | Open-market sale · S | −5,907 | $28.95 | −$171K | 21,691 |
| Ticho Barry | CHIEF MEDICAL OFFICER | Jul 01 | Open-market sale · S | −500 | $33.27 | −$16.6K | 27,598 |
| Ticho Barry | CHIEF MEDICAL OFFICER | Jul 01 | Open-market sale · S | −6,728 | $32.62 | −$219K | 28,098 |
| Allan Jonathan | GENERAL COUNSEL & CORP SEC | Jun 16 | Open-market sale · S | −1,457 | $29.95 | −$43.6K | 18,086 |
| Ticho Barry | CHIEF MEDICAL OFFICER | Jun 01 | Open-market sale · S | −1,795 | $30.58 | −$54.9K | 34,826 |
| Ticho Barry | CHIEF MEDICAL OFFICER | May 01 | Open-market sale · S | −2,243 | $32.79 | −$73.5K | 36,621 |
Loading...